Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Condition:   Classical Hodgkin Lymphoma Interventions:   Drug: Camrelizumab;   Drug: Epirubicin;   Drug: Vincristine;   Drug: Dacarbazine Sponsor:   Henan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials